nach oben

Erschienen in:

01.01.2016 | My Paper 20 Years Later

Cytomegalovirus reactivation in ICU patients

verfasst von: Laurent Papazian, Sami Hraiech, Samuel Lehingue, Antoine Roch, Laurent Chiche, Sandrine Wiramus, Jean-Marie Forel

Erschienen in: Intensive Care Medicine | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Approximately 20 years have passed since we reported our results of histologically proven cytomegalovirus (CMV) pneumonia in non-immunocompromised ICU patients. Even if there are more recent reports suggesting that CMV may worsen the outcomes for ICU patients, there is no definite answer to this question: is CMV a potential pathogen for ICU patients or is it simply a bystander?

Methods

We will describe the pathophysiology of active CMV infection and the most recent insights concerning the epidemiological aspects of these reactivations.

Major findings

Cytomegalovirus can be pathogenic by a direct organ insult (such as for the lung), by decreasing host defences against other microorganisms and/or by enhancing the body’s inflammatory response (as in acute respiratory distress syndrome). The incidence of active CMV infection is dependent on the diagnostic method used. Using the most sophisticated available biological tools, the incidence can reach 15–20 % of ICU patients (20–40 % in ICU patients with positive CMV serology). In adequately powered cohorts of patients, active CMV infection appears to be associated with worse outcomes for mechanically ventilated ICU patients.

Discussion

There is no absolute direct proof of a negative impact of active CMV infection on the health outcomes of mechanically ventilated patients. Prospective randomized trials are lacking. Future trials should examine the potential benefits for health outcomes of using antiviral treatments. Such treatments could be prophylactic, pre-emptive or used only when there is an end-organ disease.

Conclusion

Cytomegalovirus infection may affect health outcomes for ICU patients. Additional prospective trials are necessary to confirm this hypothesis.

Chiche L, Forel JM, Papazian L (2011) The role of viruses in nosocomial pneumonia. Curr Opin Infect Dis 24:152–156CrossRefPubMed

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ (2012) Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis 206:1897–1903CrossRefPubMed

Barry SM, Johnson MA, Janossy G (2000) Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant 26:591–597CrossRefPubMed

Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P, Pierrin G, Gouin F (1996) Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 84:280–287CrossRefPubMed

Papazian L, Thomas P, Bregeon F, Garbe L, Zandotti C, Saux P, Gaillat F, Drancourt M, Auffray JP, Gouin F (1998) Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 88:935–944CrossRefPubMed

Grundy JE, Shanley JD, Griffiths PD (1987) Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2:996–999CrossRefPubMed

Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L (2009) Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37:1850–1857CrossRefPubMed

Cook CH, Martin LC, Yenchar JK, Lahm MC, McGuinness B, Davies EA, Ferguson RM (2003) Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 31:1923–1929CrossRefPubMed

Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF, Eledjam JJ (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127:233–241CrossRefPubMed

10.

Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, Green JM, Storch GA, Hotchkiss RS (2014) Reactivation of multiple viruses in patients with sepsis. PLoS One 9:e98819PubMedCentralCrossRefPubMed

11.

Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, Bollet C, Fuentes P, Gouin F (1995) Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 152:1982–1991CrossRefPubMed

12.

Brenner T, Rosenhagen C, Hornig I, Schmidt K, Lichtenstern C, Mieth M, Bruckner T, Martin E, Schnitzler P, Hofer S, Weigand MA (2012) Viral infections in septic shock (VISS-trial)-crosslinks between inflammation and immunosuppression. J Surg Res 176:571–582CrossRefPubMed

13.

Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD (2006) Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 80:9151–9158PubMedCentralCrossRefPubMed

14.

Florescu DF, Kalil AC (2011) Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit. Infect Disord Drug Targets 11:354–364CrossRefPubMed

15.

Heininger A, Haeberle H, Fischer I, Beck R, Riessen R, Rohde F, Meisner C, Jahn G, Koenigsrainer A, Unertl K, Hamprecht K (2011) Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 15:R77PubMedCentralCrossRefPubMed

16.

Docke WD, Prosch S, Fietze E, Kimel V, Zuckermann H, Klug C, Syrbe U, Kruger DH, von Baehr R, Volk HD (1994) Cytomegalovirus reactivation and tumour necrosis factor. Lancet 343:268–269CrossRefPubMed

17.

Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25(Suppl 2):S123–S136CrossRefPubMed

18.

Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15:496–497PubMedCentralCrossRefPubMed

19.

Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874PubMedCentralCrossRefPubMed

20.

Boeckh M, Murphy WJ, Peggs KS (2015) Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant 21:24–29CrossRefPubMed

21.

Clari MA, Aguilar G, Benet I, Belda J, Gimenez E, Bravo D, Carbonell JA, Henao L, Navarro D (2013) Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. J Med Virol 85:1802–1810CrossRefPubMed

22.

Chilet M, Aguilar G, Benet I, Belda J, Tormo N, Carbonell JA, Clari MA, Costa E, Navarro D (2010) Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 82:1384–1391CrossRefPubMed

23.

von Muller L, Klemm A, Durmus N, Weiss M, Suger-Wiedeck H, Schneider M, Hampl W, Mertens T (2007) Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis 196:1288–1295CrossRef

24.

Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323–1326CrossRefPubMed

25.

Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735CrossRefPubMed

26.

Chiche L, Forel JM, Thomas G, Farnarier C, Cognet C, Guervilly C, Zandotti C, Vely F, Roch A, Vivier E, Papazian L (2012) Interferon-gamma production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med 40:3162–3169CrossRefPubMed

27.

Min-Oo G, Lanier LL (2014) Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med 211:2669–2680PubMedCentralCrossRefPubMed

28.

Avdic S, McSharry BP, Slobedman B (2014) Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus. Front Microbiol 5:337PubMedCentralCrossRefPubMed

29.

Coisel Y, Bousbia S, Forel JM, Hraiech S, Lascola B, Roch A, Zandotti C, Million M, Jaber S, Raoult D, Papazian L (2012) Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 7:e51340PubMedCentralCrossRefPubMed

30.

Kalil AC, Florescu DF (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 37:2350–2358CrossRefPubMed

31.

Kalil AC, Florescu DF (2011) Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis? Crit Care 15:138PubMedCentralCrossRefPubMed

32.

Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413–422PubMedCentralCrossRefPubMed

33.

Lopez Roa P, Hill JA, Kirby KA, Leisenring WM, Huang ML, Santo TK, Jerome KR, Boeckh M, Limaye AP (2015) Coreactivation of human herpesvirus 6 and cytomegalovirus is associated with worse clinical outcome in critically ill adults. Crit Care Med 43:1415–1422CrossRefPubMed

34.

Papazian L, Doddoli C, Chetaille B, Gernez Y, Thirion X, Roch A, Donati Y, Bonnety M, Zandotti C, Thomas P (2007) A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35:755–762CrossRefPubMed

35.

Siciliano RF, Castelli JB, Randi BA, Vieira RD, Strabelli TM (2014) Cytomegalovirus colitis in immunocompetent critically ill patients. Int J Infect Dis 20:71–73CrossRefPubMed

36.

Fisman DN (2000) Hemophagocytic syndromes and infection. Emerg Infect Dis 6:601–608PubMedCentralCrossRefPubMed

37.

Osawa R, Singh N (2009) Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 13:R68PubMedCentralCrossRefPubMed

38.

De Vlieger G, Meersseman W, Lagrou K, Wouters P, Wilmer A, Peetermans WE, Van den Berghe G, Van Wijngaerden E (2012) Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med 40:36–42CrossRefPubMed

39.

Ong DS, Klein Klouwenberg PM, Verduyn Lunel FM, Spitoni C, Frencken JF, Dekker HA, Schultz MJ, Bonten MJ, Cremer OL (2015) Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome. Crit Care Med 43:394–400CrossRefPubMed

40.

Forel JM, Martin-Loeches I, Luyt CE (2014) Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro. Intensive Care Med 40:1945–1949CrossRefPubMed

41.

Domart Y, Trouillet JL, Fagon JY, Chastre J, Brun-Vezinet F, Gibert C (1990) Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 97:18–22CrossRefPubMed

42.

Stephan F, Meharzi D, Ricci S, Fajac A, Clergue F, Bernaudin JF (1996) Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation. Intensive Care Med 22:1244–1249CrossRefPubMed

43.

Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G (1998) High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 26:1076–1082CrossRefPubMed

44.

Cook CH, Yenchar JK, Kraner TO, Davies EA, Ferguson RM (1998) Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 176:357–360CrossRefPubMed

45.

Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K (2001) Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 29:541–547CrossRefPubMed

46.

Desachy A, Ranger-Rogez S, Francois B, Venot C, Traccard I, Gastinne H, Denis F, Vignon P (2001) Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 32:197–203CrossRefPubMed

47.

Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV (2002) Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis 185:110–113CrossRefPubMed

48.

von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, Hampl W, Mertens T (2006) Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 12:1517–1522CrossRef

49.

Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H (2008) Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 36:3145–3150CrossRefPubMed

50.

Bordes J, Gaillard T, Maslin J, Esnault P, Goutorbe P, Brisou P (2011) Cytomegalovirus infection monitored by quantitative real-time PCR in critically ill patients. Crit Care 15:412PubMedCentralCrossRefPubMed

51.

Frantzeskaki FG, Karampi ES, Kottaridi C, Alepaki M, Routsi C, Tzanela M, Vassiliadi DA, Douka E, Tsaousi S, Gennimata V, Ilias I, Nikitas N, Armaganidis A, Karakitsos P, Papaevangelou V, Dimopoulou I (2015) Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers. J Crit Care 30:276–281CrossRefPubMed

Titel: Cytomegalovirus reactivation in ICU patients
verfasst von: Laurent Papazian
Sami Hraiech
Samuel Lehingue
Antoine Roch
Laurent Chiche
Sandrine Wiramus
Jean-Marie Forel
Publikationsdatum: 01.01.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 1/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-015-4066-9

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Cytomegalovirus reactivation in ICU patients

Abstract

Introduction

Methods

Major findings

Discussion

Conclusion

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Methods

Major findings

Discussion

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Validation and comparison of CAM-ICU and ICDSC in mild and moderate traumatic brain injury patients

Ventilatory support of patients with sepsis or septic shock in resource-limited settings

Negative randomized clinical trials (RCTs): further insight from the biostatistician’s point of view

Cholestatic liver (dys)function during sepsis and other critical illnesses

Central venous catheter malposition into pulmonary vein: an unusual cause of epileptic seizures

Does this patient have acute kidney injury? An AKI checklist

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS